Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cardlytics Sees Q4 Sales $86.000M-$96.000M vs $58.850M Est

Author: Benzinga Newsdesk | November 05, 2025 04:27pm

Cardlytics (NASDAQ:CDLX) sees Q4 sales of $86.000 million-$96.000 million vs $58.850 million analyst estimate.

Posted In: CDLX